Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥21.6bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥33.0bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥15.3bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥3.0bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥1.8bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥4.1bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥1.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥1.0bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥70.2bnat 2024-09-30Cons.Assets IFRS
Total assets¥62.8bnat 2024-03-31Cons.Assets IFRS
Total assets¥58.8bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥41.7bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥34.8bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥28.5bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥28.0bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥26.0bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥11.9bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥27.9bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥27.3bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥25.8bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥13.2bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥8.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥20.0bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥4.1bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥4.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥14.7bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥5.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥14.4bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥16.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥68.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥93.992023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥40.092023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥68.512024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.992023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥40.092023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio39.8%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.8%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥83m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥55m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥157m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥439m
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue2024-04-01 → 2024-09-30¥6.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue external2024-04-01 → 2024-09-30¥6.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentsegment profit2024-04-01 → 2024-09-30¥690m
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue2024-04-01 → 2024-09-30¥6.1bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue external2024-04-01 → 2024-09-30¥6.1bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentsegment profit2024-04-01 → 2024-09-30¥540m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥8.9bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥157m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.2bn
—segment totalrevenue2024-04-01 → 2024-09-30¥21.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥21.5bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
—segment totalsegment profit2024-04-01 → 2024-09-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥21.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥21.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥157m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥98m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥98m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥4m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥123m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥123m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥576m
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue2023-04-01 → 2023-09-30¥4.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentrevenue external2023-04-01 → 2023-09-30¥4.7bn
jpcrp040300-q2r_E37214-000Hospicereportable segmentsegment profit2023-04-01 → 2023-09-30−¥50m
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E37214-000In Home Nursingreportable segmentsegment profit2023-04-01 → 2023-09-30¥386m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue2023-04-01 → 2023-09-30¥5.1bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E37214-000Management Supportreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥123m
jpcrp040300-q2r_E37214-000Management Supportreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥15.4bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥15.2bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥123m
—segment totalsegment profit2023-04-01 → 2023-09-30¥2.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥15.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥15.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥123m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥2.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 808
ItemContextValueUnit
Operating profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember540000000JPY
Operating profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember3430000000JPY
Operating profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember55000000JPY
Operating profit loss IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3486000000JPY
Operating profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-439000000JPY
Operating profit loss IFRSCurrentYTDDuration3047000000JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember-JPY
Finance income IFRSCurrentYTDDuration_ReportableSegmentsMember-JPY
Finance income IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Finance income IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Finance income IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Finance income IFRSCurrentYTDDuration361000000JPY
Finance costs IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember-JPY
Finance costs IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember-JPY
Finance costs IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember-JPY
Finance costs IFRSCurrentYTDDuration_ReportableSegmentsMember-JPY
Finance costs IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Finance costs IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Finance costs IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Finance costs IFRSCurrentYTDDuration228000000JPY
Profit loss before tax IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_ReportableSegmentsMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Profit loss before tax IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Profit loss before tax IFRSCurrentYTDDuration3180000000JPY
Profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember-JPY
Profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember-JPY
Profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember-JPY
Profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember-JPY
Profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Profit loss IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Profit loss IFRSCurrentYTDDuration1981000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000ManagementSupportReportableSegmentMember479000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000HospiceReportableSegmentMember469000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_jpcrp040300-q2r_E37214-000InHomeNursingReportableSegmentMember244000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_ReportableSegmentsMember1192000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1196000000JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration_ReconcilingItemsMember-JPY
Depreciation and amortization operating expenses IFRSCurrentYTDDuration1196000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-11-08

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass